Torhild Warncke

Local treatment with the N-methyl-d-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action

A. Stubhaug, E. Jørum, Audun Stubhaug, 1997, Neuroscience Letters.